Peyman Hadji

5PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Major global burdens of diseaseObstetrics and gynaecologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 12, 2026
Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

G Marcucci, E Biver, J J Body

|Aug 02, 2024
Real-world efficacy of a teriparatide biosimilar (RGB-10) compared with reference teriparatide on bone mineral density, trabecular bone score, and bone parameters assessed using quantitative ultrasound, 3D-SHAPER<sup>®</sup> and high-resolution peripheral computer tomography in postmenopausal women with osteoporosis and very high fracture risk.

Peyman Hadji, Luka Kamali, Friederike Thomasius

|Jun 23, 2023
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Rebecca J Moon, Jean-Yves Reginster, Nasser M Al-Daghri

|Mar 08, 2023
The risk of thromboembolism and use of combined oral contraceptives: a comment.

Martin Birkhäuser, Bettina Böttcher, Ariane Germeyer

|Mar 25, 2022
Management of patients at very high risk of osteoporotic fractures through sequential treatments.

Elizabeth M Curtis, Jean-Yves Reginster, Nasser Al-Daghri

Pageof 1